NASDAQ:APDN Applied DNA Sciences (APDN) Stock Price, News & Analysis $4.82 -0.07 (-1.43%) Closing price 04:00 PM EasternExtended Trading$4.80 -0.02 (-0.50%) As of 04:19 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsEarningsFDA EventsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Applied DNA Sciences Stock (NASDAQ:APDN) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Applied DNA Sciences alerts:Sign Up Key Stats Today's Range$4.77▼$4.9850-Day Range$4.51▼$8.7052-Week Range$4.37▼$2,655.00Volume31,241 shsAverage Volume95,245 shsMarket Capitalization$2.12 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Applied DNA Sciences, Inc., a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. It operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services. The Therapeutic DNA Production Services segment develops and commercializes the LinearDNA platform, which enables a cell-free manufacture of high-fidelity synthetic DNA sequences for use in nucleic acid-based therapeutics. The MDx Testing Services segment provides clinical molecular diagnostics (MDx) testing and clinical laboratory testing services; COVID-19 testing services, including test scheduling, sample collection, and automated results reporting for higher education institutions, private clients, and businesses under the safeCircle trademark; polymerase chain reaction (PCR) for production and detection of DNA and RNA; and MDx test kits and related supplies, as well as Isotopic analysis testing services. The DNA Tagging and Security Products and Services segment offers SigNature Molecular Tags, which provides a methodology to authenticate goods within large and complex supply chains for materials, such as cotton, nutraceuticals, and other products; SigNify portable DNA readers and SigNify consumable reagent test kits; and fiberTyping, which uses PCR-based DNA detection to detect a product's naturally occurring DNA sequences for the purposes of product provenance authentication and supply chain security. The company was formerly known as Datalink Systems, Inc. and changed its name to Applied DNA Sciences, Inc. in 2002. Applied DNA Sciences, Inc. was founded in 1983 and is headquartered in Stony Brook, New York. Read More Applied DNA Sciences Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks16th Percentile Overall ScoreAPDN MarketRank™: Applied DNA Sciences scored higher than 16% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for Applied DNA Sciences. Earnings and Valuation0.6 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Applied DNA Sciences is -0.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Applied DNA Sciences is -0.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioApplied DNA Sciences has a P/B Ratio of 0.02. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Applied DNA Sciences' valuation and earnings. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted6.19% of the float of Applied DNA Sciences has been sold short.Short Interest Ratio / Days to CoverApplied DNA Sciences has a short interest ratio ("days to cover") of 0.3, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Applied DNA Sciences has recently decreased by 69.51%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldApplied DNA Sciences does not currently pay a dividend.Dividend GrowthApplied DNA Sciences does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted6.19% of the float of Applied DNA Sciences has been sold short.Short Interest Ratio / Days to CoverApplied DNA Sciences has a short interest ratio ("days to cover") of 0.3, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Applied DNA Sciences has recently decreased by 69.51%, indicating that investor sentiment is improving significantly. News and Social Media2.7 / 5News SentimentN/A News SentimentApplied DNA Sciences has a news sentiment score of 0.93. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.75 average news sentiment score of Industrials companies.News Coverage This WeekMarketBeat has tracked 1 news article for Applied DNA Sciences this week, compared to 1 article on an average week.Search InterestOnly 1 people have searched for APDN on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.MarketBeat Follows4 people have added Applied DNA Sciences to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Applied DNA Sciences insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 0.17% of the stock of Applied DNA Sciences is held by insiders.Percentage Held by InstitutionsOnly 22.22% of the stock of Applied DNA Sciences is held by institutions.Read more about Applied DNA Sciences' insider trading history. Receive APDN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Applied DNA Sciences and its competitors with MarketBeat's FREE daily newsletter. Email Address APDN Stock News HeadlinesApplied DNA Sciences Regains Nasdaq ComplianceJuly 9, 2025 | theglobeandmail.comApplied DNA Sciences, Inc. (APDN) - Yahoo FinanceJuly 5, 2025 | finance.yahoo.comAI Frenzy Could Send ‘EarnPhone’ SoaringThe hidden fuel behind AI? Your phone. Billions of data points — from your clicks, swipes, scrolls, and searches — are feeding the next wave of AI innovation. Big Tech is harvesting it. Mode Mobile is giving it back to you. They are creating a user-powered data economy that shares the upside, and +50M users have already generated +$325M in earnings. This isn't a theory… Mode’s 32,481% revenue growth from 2019-2022 landed them the #1 spot on Deloitte’s 2023 list of fastest growing companies in software, and they’ve secured the Nasdaq ticker $MODE ahead of a potential IPO. The offering could close any moment now. AI breakthroughs are everywhere, but these models need your data to survive. Invest in the company that allows you to share in the profits from yours.July 30 at 2:00 AM | Mode Mobile (Ad)APDN - Applied DNA Sciences Inc News - MorningstarJuly 2, 2025 | morningstar.comMApplied DNA Sciences' Stock Down on Restructuring, Job CutsJune 30, 2025 | marketwatch.comApplied DNA Sciences to focus solely on synthetic DNA, cuts 27% of staffJune 30, 2025 | msn.comAPDN Applied DNA Sciences, Inc. - Seeking AlphaJune 26, 2025 | seekingalpha.comApplied DNA Sciences Faces Nasdaq Delisting HearingJune 6, 2025 | tipranks.comSee More Headlines APDN Stock Analysis - Frequently Asked Questions How have APDN shares performed this year? Applied DNA Sciences' stock was trading at $153.00 at the beginning of the year. Since then, APDN shares have decreased by 96.8% and is now trading at $4.82. How were Applied DNA Sciences' earnings last quarter? Applied DNA Sciences Inc (NASDAQ:APDN) released its quarterly earnings data on Thursday, May, 15th. The technology company reported ($230.25) earnings per share (EPS) for the quarter, missing the consensus estimate of ($45.00) by $185.25. The technology company had revenue of $0.98 million for the quarter, compared to analysts' expectations of $1.19 million. Applied DNA Sciences had a negative trailing twelve-month return on equity of 66.95% and a negative net margin of 194.14%. When did Applied DNA Sciences' stock split? Shares of Applied DNA Sciences reverse split on Sunday, June 1st 2025.The 1-15 reverse split was announced on Sunday, June 1st 2025. The number of shares owned by shareholders was adjusted after the closing bell on Sunday, June 1st 2025. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split. How do I buy shares of Applied DNA Sciences? Shares of APDN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Applied DNA Sciences own? Based on aggregate information from My MarketBeat watchlists, some other companies that Applied DNA Sciences investors own include Zomedica (ZOM), Jumia Technologies (JMIA), Nano Dimension (NNDM), NIO (NIO), Virgin Galactic (SPCE), AST SpaceMobile (ASTS) and Advanced Micro Devices (AMD). Company Calendar Last Earnings5/15/2025Today7/30/2025Next Earnings (Estimated)8/06/2025Fiscal Year End9/30/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorIndustrials Industry PROTECTION - SFTY Sub-IndustryBusiness Services Current SymbolNASDAQ:APDN CIK744452 Webwww.adnas.com Phone(631) 240-8800Fax631-240-8900Employees70Year FoundedN/AProfitability EPS (Trailing Twelve Months)($537.48) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$6.99 million Net Margins-194.14% Pretax Margin-197.02% Return on Equity-66.95% Return on Assets-50.34% Debt Debt-to-Equity RatioN/A Current Ratio4.45 Quick Ratio4.27 Sales & Book Value Annual Sales$3.43 million Price / Sales0.63 Cash FlowN/A Price / Cash FlowN/A Book Value$215.25 per share Price / Book0.02Miscellaneous Outstanding Shares440,000Free Float434,000Market Cap$2.15 million OptionableOptionable Beta0.07 7 Stocks to Buy And Hold ForeverEnter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report This page (NASDAQ:APDN) was last updated on 7/30/2025 by MarketBeat.com Staff From Our PartnersAI Frenzy Could Send ‘EarnPhone’ SoaringThe hidden fuel behind AI? Your phone. Billions of data points — from your clicks, swipes, scrolls, and sea...Mode Mobile | SponsoredEx-Hedge Fund Manager Uncovers $100 Trillion Land ShiftTrump's Radical New Plan Could Enrich Thousands This isn't a campaign stunt. It's a $100 trillion move to u...Stansberry Research | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredStrange Investment Secret Predicts Market's Next Move?A strange market signal discovered before the Great Depression has predicted nearly every major financial even...Weiss Ratings | SponsoredI warned you about Nvidia… now look what’s happeningNvidia just got Trump’s greenlight to sell high-powered AI chips to China — and their stock surged 5% before t...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredOne stock to replace NvidiaI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Applied DNA Sciences Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Applied DNA Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.